Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
121-135 of 4385 results
Diabetes startup AnTolRx secures funding from Pfizer, JDRF and Orion Equity
AnTolRx has signed a Series A funding agreement with Pfizer, Orion Equity Partners and JDRF, a global organization funding type 1 diabetes (T1D) research.
Drug Research > Drug Discovery & Development > News
Horizon Discovery, Fulcrum partner for novel CRISPR-based target discovery in genetic diseases
By PBR Staff Writer
UK-based Horizon Discovery Group has partnered with US biotechnology firm Fulcrum Therapeutics for novel CRISPR-based target discovery in genetic diseases.
Drug Research > Drug Discovery & Development > News
Merck discontinues osteoporosis drug development on increased risk of stroke
By PBR Staff Writer
Merck said it would stop the development of its experimental osteoporosis drug, odanacatib, because it carries a higher risk of stroke.
Drug Research > Drug Discovery & Development > News
Taiho Ventures invests in Arcus Biosciences
Taiho Ventures has invested in California-based immuno-oncology firm Arcus Biosciences.
Drug Research > Drug Discovery & Development > News
Takeda gets financial support from US to develop Zika vaccine
By PBR Staff Writer
Japanese drugmaker Takeda Pharmaceutical has won US government funding to develop a vaccine for the mosquito-borne Zika virus.
Drug Research > Drug Discovery & Development > News
Singapore sees first case of pregnant woman with Zika virus
By PBR Staff Writer
Singapore has confirmed its first case of a pregnant woman testing positive for the Zika virus infection, as the number of cases of mosquito-borne virus reached 115 in the country.
Drug Research > Drug Discovery & Development > News
BioLineRx and I-Bridge Capital establish drug development JV in China
BioLineRx has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing innovative therapies in China.
Drug Research > Drug Discovery & Development > News
F-star, Denali Therapeutics partner to develop multispecific antibody platform
By PBR Staff Writer
UK-based biopharmaceutical firm F-star has signed a collaborative agreement with the US start-up Denali Therapeutics to develop a multispecific antibody platform for delivering therapeutics across the blood-brain barrier into the central nervous system (CNS).
Drug Research > Drug Discovery & Development > News
Pfizer to acquire Medivation for $14bn
By PBR Staff Writer
Pfizer has agreed to acquire US biopharmaceutical firm Medivation in a transaction valued at about $14bn.
Drug Research > Drug Discovery & Development > News
DS Biopharma launches spin-out firm focused on fibrotic conditions and pulmonary disorders
DS Biopharma has launched a spin-out company focused solely on fibrotic conditions such as non-alcoholic steatohepatitis (NASH) and pulmonary disorders such as chronic obstructive pulmonary disease (COPD) and Idiopathic pulmonary fibrosis (IPF).
Drug Research > Drug Discovery & Development > News
Hemispherx Biopharma forms scientific advisory board to advice on drug development programs
Hemispherx Biopharma has formed a scientific advisory board (SAB) to leverage its member’s scientific and pharmaceutical expertise and advice to advance the Company’s drug development programs by providing guidance on steering the company forward and capitalizing on business opportunities as well as interactions with the Food and Drug Administration.
Drug Research > Drug Discovery & Development > News
Bayer and CRISPR Therapeutics JV starts operations in Massachusetts, US
By PBR Staff Writer
Casebia Therapeutics, the joint venture (JV) between Bayer and gene editing company CRISPR Therapeutics, has commenced its operations in Cambridge, Massachusetts, US.
Drug Research > Drug Discovery & Development > News
Xenetic Biosciences partners with Excivion to develop novel combined Zika and Dengue vaccine
Xenetic Biosciences has commenced a collaboration with Excivion to develop a vaccine against Zika and dengue viruses.
Drug Research > Drug Discovery & Development > News
Caribou Biosciences develops new method to profile CRISPR-Cas9 gene editing outcomes
Caribou Biosciences announced that members of its scientific team have discovered that DNA repair outcomes following Cas9 cleavage of DNA are nonrandom and follow highly reproducible patterns for each target site.
Drug Research > Drug Discovery & Development > News
Study suggests Zika virus may damage adult brain
By PBR Staff Writer
A new study has indicated the Zika virus, which is known to affect unborn babies, may also damage adult brain cells.
Drug Research > Drug Discovery & Development > News
121-135 of 4385 results